Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kenneth Foon"'
Autor:
Wassim McHayleh, Kenneth Foon, Robert Redner, Rajesh Sehgal, Anastasios Raptis, Mounzer Agha, The Minh Luong, James J. Schlesselman, Michael Boyiadzis
Publikováno v:
Cancer. 116(12)
BACKGROUND: Elderly patients with acute myeloid leukemia (AML) are generally unable to withstand the rigors of intensive induction chemotherapy and its attendant complications. Gemtuzumab ozogamicin (GO) is an immunoconjugate that had demonstrated ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc5f369117ac919d4c71660637a0909
https://pubmed.ncbi.nlm.nih.gov/20564405
https://pubmed.ncbi.nlm.nih.gov/20564405
Autor:
Lisa Borghesi, Lela Kardava, Qi Yang, Kenneth Foon, Suzanne Lentzsch, Abbe Vallejo, Christine Milcarek
Publikováno v:
The Journal of Immunology. 182:88.7-88.7
Chronic lymphocytic leukemia (CLL) is a common malignancy characterized by the accumulation of B lymphocytes with an antigen-experienced, activated CD19+CD5+ clonal phenotype. Clinically, approximately 50% of cases will behave more aggressively. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8ded5615fffbb5abf537fdd31c9f3dd
https://doi.org/10.4049/jimmunol.182.supp.88.7
https://doi.org/10.4049/jimmunol.182.supp.88.7
Autor:
Rosamerlinda Rosales, Kaushik Sen, Kenneth Foon, Luigi Lenaz, Shamel Sanani, Ann Mohrbacher, Steven Allen
Publikováno v:
Blood. 106:4741-4741
Background: Elsamitrucin (SPI-28090) is a novel topoisomerase I and II inhibitor. An earlier small study with Elsamitrucin, conducted prior to the introduction of rituximab, showed anti-tumor activity in patients with relapsed or refractory NHL with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9d4f5b682064b405327b1ea727fab05
https://doi.org/10.1182/blood.v106.11.4741.4741
https://doi.org/10.1182/blood.v106.11.4741.4741
Autor:
Kartik Mohanty, Asim Saha, Smarajit Pal, Palash Mallick, Sunil Chatterjee, Kenneth Foon, Malaya Bhattacharya-Chatterjee
Publikováno v:
Breast Cancer Research & Treatment; Jul2007, Vol. 104 Issue 1, p1-11, 11p
Autor:
Robert Peter, Gale, Helen M, Chapel, Christopher, Bunch, Kanti R, Rai, Kenneth, Foon, Suzanne G, Courter, Dierdre, Tait
Publikováno v:
The New England journal of medicine. 319(14)
In a double-blind study, we randomly assigned 84 patients with chronic lymphocytic leukemia who were judged to be at increased risk of bacterial infection to receive intravenous immunoglobulin G (400 mg per kilogram of body weight) or a placebo every
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::879a5d7c25deef85cb1cfe67ac0b78d0
https://pubmed.ncbi.nlm.nih.gov/2901668
https://pubmed.ncbi.nlm.nih.gov/2901668